NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bactobio

Bactobio

Private
LondonHealthcare & Life Scienceshttps://www.bacto.bio/

Last Round

Convertible Debt

Dec 5, 2022

Total Funding Raised

$15.33M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bactobio is a biotechnology company that uses breakthroughs in genomics, machine learning, and bioengineering to culture previously unculturable microbes to discover novel antibiotics and sustainable plant protection solutions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

synthetic biologyantimicrobial resistanceAMRmicrobial discoverydrug discoverybiological dark matternext-generation sequencingNGSbioinformaticsantibiotic discoveryfungicide discoverybiotech R&DAI-driven discoverydirected evolutionwet-lab automationbiotech platformdeep tech biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bactobio Comps

Public and private peers based on sector, stage, and business model.

Bactobio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bactobio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtDec 5, 2022
GrantOct 25, 2022
GrantApr 1, 2022
SeedOct 6, 2021
GrantMay 1, 2021
Pre Seed
Jul 1, 2020

Key People

Founding team and executive leadership

Mark Wilkinson

Co-founder And Chief Scientific Officer

Founding Team

Daniel Blicher Hansen

Cofounder And CEO

Founding Team

Bactobio Investors

Notable investors and investment history

Bactobio investors
InvestorRounds
Innovate UKGrant
UK Agri-Tech CentreSeed
Entangle S.A.Convertible Debt
Bridford GroupConvertible Debt
Innovate UKGrant, Seed
LendableConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    First product commercialization planned for H1 2026.

  • Sep 1, 2025

    Partnering with PIPS, iCASE, and MRC LID for PhD internships.

Bactobio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bactobio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bactobio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range54
Year Founded2020
Last FundingDec 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.